Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tanimilast in COPD
NCT01730404Phase 2Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Oct 2012
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of tanimilast in chronic obstructive pulmonary disease (COPD), sponsored by Chiesi Farmaceutici S.p.A.. Started Oct 2012; status: completed.
02
Drugs
tanimilast
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01730404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01730404.